CD1 presentation of self glycolipids and lipopeptides to T cells
CD1 将自身糖脂和脂肽呈递给 T 细胞
基本信息
- 批准号:8655786
- 负责人:
- 金额:$ 36.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-09-20 至 2017-04-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAmino AcidsAnimal ModelAntigensAutoantigensAutoimmune DiseasesAutoimmune ProcessAutoimmunityBindingBiologyBrainCD1 AntigensCellsColonComplexData SetDendritic CellsDevelopmentDiabetes MellitusDiagnostic testsGene DeletionGlycolipidsGrantHigh Pressure Liquid ChromatographyHome environmentHomeostasisHumanImmuneImmune responseIndividualJointsKnowledgeLangerhans cellLeadLigandsLipid BindingLipidsLiquid ChromatographyLungMass Spectrum AnalysisMeasuresMediatingMolecularMolecular StructureMolecular TargetMultiple SclerosisMusNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNatureOrganOrgan ModelPancreasPathway interactionsPatientsPatternPeptide/MHC ComplexPeptidesPlayProteinsPsoriasisResearchRheumatoid ArthritisRoleSelf PerceptionSkinStructureSyndromeSystemT cell responseT-Cell ActivationT-Cell ReceptorT-LymphocyteTestingThyroid GlandThyroiditisTissuesTo autoantigenWorkautoreactive T cellautoreactivitybasebiliary tractcell typechemical propertycytokinedensityhuman tissuein vivointerleukin-22microsomal triglyceride transfer proteinmouse modelresearch studytool
项目摘要
DESCRIPTION (provided by applicant): CD1 presentation of self glycolipids and lipopeptides to T cells T cells that recognize autoantigens play a central role in psoriasis, thyroiditis, diabetes, multiple sclerosis, rheumatoid arthritis and other human autoimmune diseases. For many years all autoantigens for T cells were thought to be peptides bound to MHC proteins. However, new evidence shows that cellular lipids activated T cells when bound to CD1 proteins expressed on Langerhans cells and other dendritic cells. Recent studies show that CD1 and lipid autoreactive T cells occur frequently in individuals, such that they can now be considered a normal part of human immune responses. In particular, CD1a activates T cells that make IL-22, a cytokine that contributes to psoriasis. Whereas nearly all prior study of T cell autoantigens have focused on peptides, these findings considerably broaden the spectrum of autoantigens to include a variety of cellular lipids. Discovery of CD1 autoreactive T cells opens up a new and general pathway for discovering autoantigens that contribute to autoimmune disease and the use of lipids to treat autoimmune diseases. Whereas mouse models provide important information about in vivo function, tissue antigens and CD1-mediated T cell responses differ between mouse and human systems. Therefore, this proposal uses human tissues from normal donors and autoimmune disease patients to isolate new antigens and new T cell types. Specifically, experiments will use mass spectrometry to broadly measure the mass and chemical properties of lipids bound to human CD1a, CD1b and CD1c proteins. From this large pool of candidate autoantigens, lipids that lead to the strongest T cell activation will be identifed using T cell clones and polyclonal T cells from patients. After isolating antigenic compounds from tissues by liquid chromatography, their molecular structures will be solved by mass spectrometry. CD1 proteins and antigens will be used to measure T cell responses in normal donors and patients to test new general hypotheses about the role of CD1 and interleukin-22 in skin and thyroid autoimmunity.
描述(由申请人提供):自身糖脂和脂肽向T细胞的CD 1呈递识别自身抗原的T细胞在银屑病、甲状腺炎、糖尿病、多发性硬化症、类风湿性关节炎和其它人类自身免疫性疾病中起中心作用。多年来,所有T细胞的自身抗原都被认为是与MHC蛋白结合的肽。然而,新的证据表明,当细胞脂质与朗格汉斯细胞和其他树突状细胞上表达的CD 1蛋白结合时,T细胞被激活。最近的研究表明,CD 1和脂质自身反应性T细胞在个体中频繁发生,因此它们现在可以被认为是人类免疫反应的正常部分。特别是,CD 1a激活T细胞,使IL-22,一种细胞因子,有助于银屑病。尽管几乎所有先前的T细胞自身抗原研究都集中在肽上,但这些发现大大拓宽了自身抗原的范围,包括各种细胞脂质。CD 1自身反应性T细胞的发现为发现导致自身免疫性疾病的自身抗原和使用脂质治疗自身免疫性疾病开辟了一条新的通用途径。尽管小鼠模型提供了有关体内功能的重要信息,但小鼠和人类系统之间的组织抗原和CD 1介导的T细胞反应有所不同。因此,该提案使用来自正常供体和自身免疫性疾病患者的人体组织来分离新的抗原和新的T细胞类型。具体而言,实验将使用质谱法广泛测量与人CD 1a、CD 1b和CD 1c蛋白结合的脂质的质量和化学性质。从这个大的候选自身抗原库中,将使用来自患者的T细胞克隆和多克隆T细胞来鉴定导致最强T细胞活化的脂质。在通过液相色谱法从组织中分离抗原化合物之后,将通过质谱法解析其分子结构。CD 1蛋白和抗原将用于测量正常供体和患者的T细胞反应,以测试关于CD 1和白细胞介素-22在皮肤和甲状腺自身免疫中的作用的新的一般假设。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID Branch MOODY其他文献
DAVID Branch MOODY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID Branch MOODY', 18)}}的其他基金
Chemical Biological Discovery of Lipid Virulence Factors in the Major Bacterial Pathogens
主要细菌病原体中脂质毒力因子的化学生物学发现
- 批准号:
10518252 - 财政年份:2022
- 资助金额:
$ 36.11万 - 项目类别:
Chemical Biological Discovery of Lipid Virulence Factors in the Major Bacterial Pathogens
主要细菌病原体中脂质毒力因子的化学生物学发现
- 批准号:
10651853 - 财政年份:2022
- 资助金额:
$ 36.11万 - 项目类别:
Study of M. tuberculosis under human host selection to identify virulence and barrier lipids (Project 1)
研究人类宿主选择下的结核分枝杆菌以确定毒力和屏障脂质(项目 1)
- 批准号:
10612035 - 财政年份:2021
- 资助金额:
$ 36.11万 - 项目类别:
Metabolic adaptions of Mycobacterium tuberculosis at diverse host-pathogen interfaces
结核分枝杆菌在不同宿主-病原体界面的代谢适应
- 批准号:
10630740 - 财政年份:2021
- 资助金额:
$ 36.11万 - 项目类别:
Metabolic determinants of Mtb virulence, vulnerability and variation
结核分枝杆菌毒力、脆弱性和变异的代谢决定因素
- 批准号:
10438911 - 财政年份:2021
- 资助金额:
$ 36.11万 - 项目类别:
相似海外基金
Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
- 批准号:
BB/Y006380/1 - 财政年份:2024
- 资助金额:
$ 36.11万 - 项目类别:
Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
- 批准号:
24K17112 - 财政年份:2024
- 资助金额:
$ 36.11万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
- 批准号:
23K04668 - 财政年份:2023
- 资助金额:
$ 36.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
- 批准号:
23K06918 - 财政年份:2023
- 资助金额:
$ 36.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
- 批准号:
23K05758 - 财政年份:2023
- 资助金额:
$ 36.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Design and Synthesis of Fluorescent Amino Acids: Novel Tools for Biological Imaging
荧光氨基酸的设计与合成:生物成像的新工具
- 批准号:
2888395 - 财政年份:2023
- 资助金额:
$ 36.11万 - 项目类别:
Studentship
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
- 批准号:
2300890 - 财政年份:2023
- 资助金额:
$ 36.11万 - 项目类别:
Continuing Grant
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
- 批准号:
10761044 - 财政年份:2023
- 资助金额:
$ 36.11万 - 项目类别:
Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial
生活方式、支链氨基酸和心血管危险因素:一项随机试验
- 批准号:
10728925 - 财政年份:2023
- 资助金额:
$ 36.11万 - 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
- 批准号:
10757309 - 财政年份:2023
- 资助金额:
$ 36.11万 - 项目类别: